ID   SK-MEL-315-03
AC   CVCL_E091
SY   SKMEL-315-03
DR   Cosmic; 1669241
DR   Wikidata; Q54954071
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E090 ! SK-MEL-315-02
OI   CVCL_E092 ! SK-MEL-315-05
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
RX   PubMed=21725359; DOI=10.1038/onc.2011.250; PMCID=PMC3267014;
RA   Xing, Feng
RA   Persaud, Yogindra
RA   Pratilas, Christine A.
RA   Taylor, Barry Stephen
RA   Janakiraman, Manickam
RA   She, Qing-Bai
RA   Gallardo, Humilidad F.
RA   Liu, Cai-Lian
RA   Merghoub, Taha
RA   Hefter, Blake E.
RA   Dolgalev, Igor
RA   Viale, Agnes J.
RA   Heguy, Adriana
RA   de Stanchina, Elisa
RA   Cobrinik, David
RA   Bollag, Gideon
RA   Wolchok, Jedd David
RA   Houghton, Alan N.
RA   Solit, David B.
RT   "Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF
RT   dependence in melanomas harboring (V600E)BRAF.";
RL   Oncogene 31:446-457(2012).
//